Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MRMD
$0.08
-7.09%
MRMD
· Marimed Inc.
Market Cap
$33.45M
Shares
403.04M
All earnings calls
Earnings call · FY2024 Q3
Marimed Inc. (MRMD) Q3 2024 Earnings Call
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$40.59M
+4.6% YoY
Diluted EPS
$0.00
Gross margin
41.3%
-2.1 pp YoY
Net income
-$1.01M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 6, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue Growth
Initiated
full-year 2024
|
6% – 8% | — | |
|
Capital Expenditures
Initiated
full-year 2024
|
$11M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 6, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 7, 2024 · complete as-filed document